AirSculpt Technologies, Inc. (AIRS)
USD 1.7
(-0.29%)
USD 1.7
(-0.29%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 89.4 Million USD | -8.8% |
| 2022 | 98.03 Million USD | 30.3% |
| 2021 | 75.23 Million USD | 91.01% |
| 2020 | 39.38 Million USD | -1.46% |
| 2019 | 39.97 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 90.59 Million USD | 3.07% |
| 2024 Q1 | 87.89 Million USD | -1.69% |
| 2023 Q4 | 89.4 Million USD | -3.07% |
| 2023 FY | 89.4 Million USD | -8.8% |
| 2023 Q2 | 91.64 Million USD | -10.32% |
| 2023 Q1 | 102.19 Million USD | 4.25% |
| 2023 Q3 | 92.23 Million USD | 0.64% |
| 2022 Q2 | 69.53 Million USD | -6.69% |
| 2022 Q1 | 74.52 Million USD | -0.95% |
| 2022 FY | 98.03 Million USD | 30.3% |
| 2022 Q4 | 98.03 Million USD | -1.59% |
| 2022 Q3 | 99.61 Million USD | 43.25% |
| 2021 Q1 | 10.37 Million USD | -73.65% |
| 2021 FY | 75.23 Million USD | 91.01% |
| 2021 Q2 | 81.74 Million USD | 687.56% |
| 2021 Q4 | 75.23 Million USD | -6.71% |
| 2021 Q3 | 80.65 Million USD | -1.33% |
| 2020 FY | 39.38 Million USD | -1.46% |
| 2020 Q4 | 39.38 Million USD | 0.0% |
| 2020 Q1 | 5.12 Million USD | 0.0% |
| 2019 FY | 39.97 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 93.662% |
| Addus HomeCare Corporation | 110.39 Million USD | 19.01% |
| Amedisys, Inc. | 341.35 Million USD | 73.808% |
| American Oncology Network, Inc. | 99.78 Million USD | 10.402% |
| Astrana Health, Inc. | 27.2 Million USD | -228.614% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 93.856% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | 40461.878% |
| biote Corp. | 25.86 Million USD | -245.611% |
| Cryo-Cell International, Inc. | 10.48 Million USD | -752.3% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | 855.948% |
| COMPASS Pathways plc | -187.58 Million USD | 147.661% |
| DocGo Inc. | -12.78 Million USD | 799.085% |
| The Ensign Group, Inc. | 1.36 Billion USD | 93.434% |
| Healthcare Services Group, Inc. | -10.69 Million USD | 935.961% |
| InnovAge Holding Corp. | 56.08 Million USD | -59.4% |
| Assure Holdings Corp. | 14.68 Million USD | -508.95% |
| The Joint Corp. | -2.47 Million USD | 3705.866% |
| LifeStance Health Group, Inc. | 432.21 Million USD | 79.315% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | 1577.648% |
| ModivCare Inc. | 1.13 Billion USD | 92.139% |
| NewGenIvf Group Limited | 278.44 Thousand USD | -32008.573% |
| Novo Integrated Sciences, Inc. | 4.05 Million USD | -2104.656% |
| Option Care Health, Inc. | 822.56 Million USD | 89.131% |
| P3 Health Partners Inc. | 83.7 Million USD | -6.808% |
| P3 Health Partners Inc. | 83.7 Million USD | -6.808% |
| The Pennant Group, Inc. | 323.57 Million USD | 72.369% |
| Surgery Partners, Inc. | 2.86 Billion USD | 96.88% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | 3048.774% |
| Talkspace, Inc. | -123.9 Million USD | 172.155% |
| Talkspace, Inc. | -123.9 Million USD | 172.155% |
| The Oncology Institute, Inc. | 86.32 Million USD | -3.567% |
| The Oncology Institute, Inc. | 86.32 Million USD | -3.567% |